Quarterly report pursuant to Section 13 or 15(d)

ASSET PURCHASE AGREEMENT WITH TRIGEMINA (Details Narrative)

v3.23.1
ASSET PURCHASE AGREEMENT WITH TRIGEMINA (Details Narrative)
Jun. 11, 2020
USD ($)
$ / shares
shares
Assignment and Assumption Agreement [Member]  
Asset Acquisition [Line Items]  
Payment for purchase of assets $ 250,241
Trigemina Inc [Member] | Asset Purchase Agreement [Member]  
Asset Acquisition [Line Items]  
Payment for purchase of assets $ 824,759
Number of shares issued (in shares) | shares 62,500
Common stock value (per share) | $ / shares $ 21.76
Research and development costs $ 2,400,000